CRISPR Therapeutics
Crispr Therapeutics, founded in 2013 and headquartered in Zug, Switzerland, is a developer of gene-based medications that target diseases at the molecular level.
Last updated on
About CRISPR Therapeutics
Founded
2013Estimated Revenue
$500M-$1BEmployees
251-1KFunding / Mkt. Cap
$56MCategory
Sector
Health CareIndustry Group
Pharmaceuticals, Biotechnology & Life SciencesIndustry
PharmaceuticalsSIC Code
2834NAICs Code
62151Location
City
CambridgeState
MassachusettsCountry
United StatesTech Stack (95)
